Search

Ventricular assist devices (VADs) are now increasingly used to prolong the lives of end-stage heart failure patients. These patients vary greatly in age, alertness, activity, and home environment. In daily routine, but especially in emergencies or in conjunction with non-VAD-correlated diseases, the untrained, intuitive use and application of VAD peripherals by relatives, laypersons, and paramedics becomes important. Correct intuitive use may be a matter of life and death. The aim of this study was to evaluate the intuitive usability of these systems and to identify key features needed to optimize intuitive use. Paramedics (n=96) were confronted with a simulated emergency situation involving VAD peripherals mounted on a dummy. Three conditions were simulated: the VAD disconnected from its power source (n=44); both VAD batteries empty (n=44); and a discharged VAD battery mistakenly connected in place of a charged one (n=8). Two VAD systems were assessed: the Heartware HVAD and the Thoratec HeartMate II. An appropriate emergency card developed by our center was available in each case. Actions were videotaped, response times were measured, and a standardized questionnaire was completed after the simulation. The problem was solved by 71% of the participants (HVAD 83%, HMII 60%) with 87% using the emergency card. Only 4% could solve the problem without. Cardiac massage, which was unnecessary, was started by 44%, while 18% complained about unnecessarily difficult conditions (e.g., irritation from the acoustic alarm, complexity of the emergency card, error-prone procedures). Better component labeling (e.g., displays, control elements, connectors) was recommended by 56%. A thoroughly color-coded connection system was especially desired. Cable- and connector-related difficulties were reported by 23%. The study indicated that VAD systems should be self-explaining, with clear labeling of components and connectors, that a clearer emergency card is pivotal and that similar basic handling and emergency procedures for all VAD types would be desirable.

We present a regimen for anticoagulation in the immediate postoperative period after left ventricular assist device (LVAD) implantation using low molecular weight heparin (LMWH) as an alternative to unfractionated heparin. Between May and September 2007, eight consecutive patients undergoing LVAD implantation for advanced heart failure received the LMWH nadroparin. Nadroparin was given twice daily to achieve anti-Factor Xa activity target peak levels of 0.4 +/- 0.1 U/mL. The antiplatelet therapy consisted of aspirin (100 mg/day) and dipyridamole (3 x 75 mg/day). One patient underwent heart transplantation, three patients died, and four patients continued to receive device support. The median duration of support was 78 days (range, 46 to 174). No major bleeding was observed; minor bleeding occurred in three patients. In two patients, pump thrombosis was suspected. There were two ischemic and no hemorrhagic strokes. The use of LMWH may provide a new anticoagulation treatment option in the immediate postoperative period after LVAD implantation.

Ventricular assist devices (VADs) are now increasingly used to prolong the lives of end-stage heart failure patients. These patients vary greatly in age, alertness, activity, and home environment. In daily routine, but especially in emergencies or in conjunction with non-VAD-correlated diseases, the untrained, intuitive use and application of VAD peripherals by relatives, laypersons, and paramedics becomes important. Correct intuitive use may be a matter of life and death. The aim of this study was to evaluate the intuitive usability of these systems and to identify key features needed to optimize intuitive use. Paramedics (n=96) were confronted with a simulated emergency situation involving VAD peripherals mounted on a dummy. Three conditions were simulated: the VAD disconnected from its power source (n=44); both VAD batteries empty (n=44); and a discharged VAD battery mistakenly connected in place of a charged one (n=8). Two VAD systems were assessed: the Heartware HVAD and the Thoratec HeartMate II. An appropriate emergency card developed by our center was available in each case. Actions were videotaped, response times were measured, and a standardized questionnaire was completed after the simulation. The problem was solved by 71% of the participants (HVAD 83%, HMII 60%) with 87% using the emergency card. Only 4% could solve the problem without. Cardiac massage, which was unnecessary, was started by 44%, while 18% complained about unnecessarily difficult conditions (e.g., irritation from the acoustic alarm, complexity of the emergency card, error-prone procedures). Better component labeling (e.g., displays, control elements, connectors) was recommended by 56%. A thoroughly color-coded connection system was especially desired. Cable- and connector-related difficulties were reported by 23%. The study indicated that VAD systems should be self-explaining, with clear labeling of components and connectors, that a clearer emergency card is pivotal and that similar basic handling and emergency procedures for all VAD types would be desirable.

The purpose of this study was the investigation of the usability and ergonomics of ventricular assist devices (VADs) in everyday usage. Patients with four different VAD types were observed. After implantation, instruction, and discharge from the hospital, the patients returned on a regular basis to the outpatient clinic, where the investigation took place. Data collection took place in two phases. In phase I home-released VAD patients were asked about perceived problems with the system at home. Additionally health-care professionals were interviewed to gather information on frequent VAD inconveniences and shortcomings. This inquiry resulted in a standardized self-assessment questionnaire and a manual skill test, which were performed in phase II by the whole collective (16 patients and ongoing). As a result, 38% of the patients disconnected parts of their system unintentionally at least once. All of them ascribed this problem to their own carelessness. Thirty-eight percent had to replace a cable. Seventy-five percent desired an additional cable strain relief. Thirty-eight percent suffered from rubbing of parts on the body. Sixty-three percent used a separate repository aside from the factory-provided transportation systems. The overall noise emission (pump, ventilators, and alarms) annoyed 56%; however, for 32% the alarm signals were too quiet to wake them up. No correlation between the assessed manual skills and the number of adverse events was found. To conclude, this preliminary study revealed considerable potential for improvements in the usability of ventricular assist systems.

We present a regimen for anticoagulation in the immediate postoperative period after left ventricular assist device (LVAD) implantation using low molecular weight heparin (LMWH) as an alternative to unfractionated heparin. Between May and September 2007, eight consecutive patients undergoing LVAD implantation for advanced heart failure received the LMWH nadroparin. Nadroparin was given twice daily to achieve anti-Factor Xa activity target peak levels of 0.4 +/- 0.1 U/mL. The antiplatelet therapy consisted of aspirin (100 mg/day) and dipyridamole (3 x 75 mg/day). One patient underwent heart transplantation, three patients died, and four patients continued to receive device support. The median duration of support was 78 days (range, 46 to 174). No major bleeding was observed; minor bleeding occurred in three patients. In two patients, pump thrombosis was suspected. There were two ischemic and no hemorrhagic strokes. The use of LMWH may provide a new anticoagulation treatment option in the immediate postoperative period after LVAD implantation.